Stay updated on HBV Drug SB 9200 Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page.
Latest updates to the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows Revision: v3.3.4 instead of v3.3.3. The rest of the content appears unchanged.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe page adds a Locations section with Alberta, British Columbia, Ontario, Gangwon-do, and Gyeongsangnam-do, and removes the corresponding location blocks; the HHS Vulnerability Disclosure link is also removed.SummaryDifference0.5%
- Check51 days agoChange DetectedRevision: v3.3.2 supersedes v3.3.1. No substantive study information or dates appear to have changed.SummaryDifference0.0%
- Check58 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed, a minor metadata update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check66 days agoChange DetectedThe government funding status notice was removed from the Study Details page. This change does not affect trial details, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check80 days agoChange DetectedNo additions or deletions were detected for this study page; the content remains unchanged.SummaryDifference0.3%
Stay in the know with updates to HBV Drug SB 9200 Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page.